middle.news
Clarity Pharmaceuticals Unveils Breakthrough Prostate Cancer Diagnostic Data at Top Global Conferences
7:03pm on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Clarity Pharmaceuticals Unveils Breakthrough Prostate Cancer Diagnostic Data at Top Global Conferences
7:03pm on Monday 2nd of June, 2025 AEST
Key Points
Two abstracts on COBRA and CLARIFY trials accepted at ASCO GU 2025
COBRA study also selected for presentation at AUA Annual Meeting 2025
64Cu-SAR-bisPSMA detects more lesions earlier than standard PSMA PET agents
High true positivity rate confirmed by histopathology in up to 78% of biopsied lesions
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
CU6
OPEN ARTICLE